All content for The Psychedelic Invest Podcast is the property of PsychedelicInvest.com and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Psychedelic Invest Podcast, hosted by Bruce Eckfeldt, explores the leaders bringing psychedelic medicines to the mainstream.
Darryl Hudson is Developing Psilocybin-Based Therapeutics
The Psychedelic Invest Podcast
36 minutes 14 seconds
2 years ago
Darryl Hudson is Developing Psilocybin-Based Therapeutics
On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Darryl Hudson, the Co-Founder and CIO of GoodCap Pharmaceuticals.
Darryl Hudson is a PhD in Molecular Biology and Genetics and is active in the Hemp, Cannabis and Psychedelic Drug Development Industries.
GoodCap Pharmaceuticals Inc. (goodcap.com) is a leading Canadian drug development company devoted to harnessing and applying the physical and mental health benefits of mushrooms and mushroom-derived compounds. GoodCap is a leader in formulation, research and development of psilocybin-based therapeutic products and is dedicated to discovering natural therapies for inflammatory disorders and mental health conditions.
The Psychedelic Invest Podcast
The Psychedelic Invest Podcast, hosted by Bruce Eckfeldt, explores the leaders bringing psychedelic medicines to the mainstream.
